Clinical evaluation of commercial nucleic acid amplification tests in patients with suspected sepsis
Authors:
- Lars LjungströmLLLars Ljungström
- Helena EnrothHEHelena Enroth
- Berndt Eb ClaessonBCBerndt Eb Claesson
- Ida OvemyrIOIda Ovemyr
- Jesper KarlssonJKJesper Karlsson
- Berit FröbergBFBerit Fröberg
- Anna-Karin BrodinABAnna-Karin Brodin
- Anna-Karin PernestigAPAnna-Karin Pernestig
- Gunnar JacobssonGJGunnar Jacobsson
- Rune AnderssonRARune Andersson
- Diana KarlssonDKDiana Karlsson
Open Access
- 28 April 2015
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 15 (1) , 1-10
Abstract
Sepsis is a serious medical condition requiring timely administered, appropriate antibiotic therapy. Blood culture is regarded as the gold standard for aetiological diagnosis of sepsis, but it suffers from low sensitivity and long turnaround time. Thus, nucleic acid amplification tests (NAATs) have emerged to shorten the time to identification of causative microbes. The aim of the present study was to evaluate the clinical utility in everyday practice in the emergency department of two commercial NAATs in patients suspected with sepsis. During a six-week period, blood samples were collected consecutively from all adult patients admitted to the general emergency department for suspicion of a community-onset sepsis and treated with intravenous antibiotics. Along with conventional blood cultures, multiplex PCR (Magicplex™) was performed on whole blood specimens whereas portions from blood culture bottles were used for analysis by microarray-based assay (Prove-it™). The aetiological significance of identified organisms was determined by two infectious disease physicians based on clinical presentation and expected pathogenicity. Among 382 episodes of suspected sepsis, clinically relevant microbes were detected by blood culture in 42 episodes (11%), by multiplex PCR in 37 episodes (9.7%), and by microarray in 32 episodes (8.4%). Although moderate agreement with blood culture (kappa 0.50), the multiplex PCR added diagnostic value by timely detection of 15 clinically relevant findings in blood culture-negative specimens. Results of the microarray corresponded very well to those of blood culture (kappa 0.90), but were available just marginally prior to blood culture results. The use of NAATs on whole blood specimens in adjunct to current culture-based methods provides a clinical add-on value by allowing for detection of organisms missed by blood culture. However, the aetiological significance of findings detected by NAATs should be interpreted with caution as the high analytical sensitivity may add findings that do not necessarily corroborate with the clinical diagnosis.Keywords
This publication has 37 references indexed in Scilit:
- Multiplex PCR System for Rapid Detection of Pathogens in Patients with Presumed Sepsis – A Systemic Review and Meta-AnalysisPLOS ONE, 2013
- Evaluation of a Polymerase Chain Reaction Assay for Pathogen Detection in Septic Patients under Routine Condition: An Observational StudyPLOS ONE, 2012
- DNAemia Detection by Multiplex PCR and Biomarkers for Infection in Systemic Inflammatory Response Syndrome PatientsPLOS ONE, 2012
- Multiplex PCR Allows Rapid and Accurate Diagnosis of Bloodstream Infections in Newborns and Children with Suspected SepsisJournal of Clinical Microbiology, 2011
- Evaluation of a commercial multiplex PCR test (SeptiFast) in the etiological diagnosis of community-onset bloodstream infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kitCritical Care, 2010
- Diagnosis of Bacteremia in Whole-Blood Samples by Use of a Commercial Universal 16S rRNA Gene-Based PCR and Sequence AnalysisJournal of Clinical Microbiology, 2009
- Pathogens Associated With Sepsis in Newborns and Young Infants in Developing CountriesThe Pediatric Infectious Disease Journal, 2009
- Association between Streptococcus infantarius (Formerly S. bovis II/1) Bacteremia and Noncolonic CancerJournal of Clinical Microbiology, 2008
- Detection of Bloodstream Infections in Adults: How Many Blood Cultures Are Needed?Journal of Clinical Microbiology, 2007